Cargando…
SAVVY Vaginal Gel (C31G) for Prevention of HIV Infection: A Randomized Controlled Trial in Nigeria
BACKGROUND: The objective of this trial was to determine the effectiveness of 1.0% C31G (SAVVY) in preventing male-to-female vaginal transmission of HIV infection among women at high risk. METHODOLOGY/PRINCIPAL FINDINGS: This was a Phase 3, double-blind, randomized, placebo-controlled trial. Partici...
Autores principales: | Feldblum, Paul J., Adeiga, Adesina, Bakare, Rashidi, Wevill, Silver, Lendvay, Anja, Obadaki, Fatimah, Olayemi, M. Onikepe, Wang, Lily, Nanda, Kavita, Rountree, Wes |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2190795/ https://www.ncbi.nlm.nih.gov/pubmed/18213382 http://dx.doi.org/10.1371/journal.pone.0001474 |
Ejemplares similares
-
SAVVY® (C31G) Gel for Prevention of HIV infection in Women: A Phase 3, Double-Blind, Randomized, Placebo-Controlled Trial in Ghana
por: Peterson, Leigh, et al.
Publicado: (2007) -
A Multi-Compartment, Single and Multiple Dose Pharmacokinetic Study of the Vaginal Candidate Microbicide 1% Tenofovir Gel
por: Schwartz, Jill L., et al.
Publicado: (2011) -
Developing Political Savvy
por: Gentry, William
Publicado: (2012) -
Tech-savvy reading promotion
por: Keane, Nancy J
Publicado: (2019) -
The Savvy Student's Guide to Online Learning
por: Sosulski, Kristen
Publicado: (2013)